Dr. Adeel Basit Shibli, MD

Dr. Shibli practices at Texas GI Endoscopy Center in Mesquite, Texas.

Dr. Shibli's NPI, 1427182872, was assigned on March 16, 2007. Dr. Shibli graduated from Dow University of Health Sciences in 1997. Dr. Shibli holds Texas license P0137.

Dr. Shibli's primary practice is Texas GI Endoscopy Center, at 2704 Galloway Suite 102, Mesquite, TX 75150. The practice phone is (972) 270-3590.

Dr. Shibli's primary practice is Texas GI Endoscopy Center in Mesquite, Texas. Dr. Shibli is also affiliated with Dallas Regional Medical Center. The medical group on file is Dallas Medical Physician Group. Dmand AI also links Dr. Shibli to 1 more hospital, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shibli practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Shibli's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Shibli is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shibli's licenses on file in 3 states: Texas, Pennsylvania and Illinois.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Shibli treats.

CMS data shows 1,168 Medicare services from Dr. Shibli across 11 procedure codes in 2024, for 224 Medicare patients. Medicare paid $120,433 for them.

CMS counts 224 Medicare patients who saw Dr. Shibli in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shibli's median patient age at 68, with 54% women.

In 2024, Dr. Shibli wrote 2,024 Medicare Part D claims for 256 patients. 36% of them were for generic drugs. CMS names the drug for 1,932 of them, across 25 drugs with 11 or more claims each, at $471,833 in total drug cost. In 2023, CMS named 1,784 claims across 25 drugs.

Dr. Shibli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Shibli in 2022. Dr. Shibli's most frequent co-authors are Alan William Skolnick, MD and Joseph Varon, MD.

CMS Open Payments shows 44 general payments to Dr. Shibli from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sunovion Pharmaceuticals Inc. paid the most, $191.

Dr. Shibli graduated from Dow University of Health Sciences in 1997.

Dr. Shibli is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.